[b0]
via grobid
|
The biology of uveal melanoma
Adriana Amaro,
Rosaria Gangemi,
Francesca Piaggio,
Giovanna Angelini,
Gaia Barisione,
Silvano Ferrini,
Ulrich Pfeffer
2017
Cancer Metastasis Review
doi:10.1007/s10555-017-9663-3
pmcid:PMC5385203
pmid:28229253
|
web.archive.org
[PDF]
|
[b1]
via grobid
|
Albert DM, Niffenegger AS, Willson JK. Treatment of metastatic uveal melanoma: review and recommendations.
|
|
[b2]
via grobid
|
Treatment of metastatic uveal melanoma: Review and recommendations
Daniel M. Albert,
Arysol Soltero Niffenegger,
James K.V. Willson
1992
Survey of ophthalmology
doi:10.1016/s0039-6257(05)80024-4
pmid:1589858
|
|
[b3]
via grobid
|
Very Long-Term Prognosis of Patients with Malignant Uveal Melanoma
Emma Kujala,
Teemu Ma¨kitie,
Tero Kivela¨
2003
Investigative Ophthalmology and Visual Science
doi:10.1167/iovs.03-0538
pmid:14578381
|
web.archive.org
[PDF]
|
[b4]
via grobid
|
Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma
2005
Archives of Ophthalmology
doi:10.1001/archopht.123.12.1639
pmid:16344433
|
|
[b5]
via grobid
|
Assessment of Metastatic Disease Status at Death in 435 Patients With Large Choroidal Melanoma in the Collaborative Ocular Melanoma Study (COMS)
2001
Archives of Ophthalmology
doi:10.1001/archopht.119.5.670
pmid:11346394
|
web.archive.org
[PDF]
|
[b6]
via grobid
|
Adoptive T-Cell Therapy for Cancer
[chapter]
James C. Yang,
Steven A. Rosenberg
2016
Advances in Immunology
doi:10.1016/bs.ai.2015.12.006
pmid:26923004
|
web.archive.org
[PDF]
|
[b7]
via grobid
|
MHC Class II-Transduced Tumor Cells Originating in the Immune-Privileged Eye Prime and Boost CD4+ T Lymphocytes that Cross-react with Primary and Metastatic Uveal Melanoma Cells
J. J. Bosch,
J. A. Thompson,
M. K. Srivastava,
U. K. Iheagwara,
T. G. Murray,
M. Lotem,
B. R. Ksander,
S. Ostrand-Rosenberg
2007
Cancer Research
doi:10.1158/0008-5472.can-06-3770
pmid:17483366
|
web.archive.org
[PDF]
|
[b8]
via grobid
|
Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells
Jacobus J. Bosch,
Uzoma K. Iheagwara,
Sarah Reid,
Minu K. Srivastava,
Julie Wolf,
Michal Lotem,
Bruce R. Ksander,
Suzanne Ostrand-Rosenberg
2009
Cancer Immunology and Immunotherapy
doi:10.1007/s00262-009-0729-0
pmcid:PMC2800822
pmid:19557412
|
web.archive.org
[PDF]
|
[b9]
via grobid
|
Tumor Cell Programmed Death Ligand 1-Mediated T Cell Suppression Is Overcome by Coexpression of CD80
S. T. Haile,
J. J. Bosch,
N. I. Agu,
A. M. Zeender,
P. Somasundaram,
M. K. Srivastava,
S. Britting,
J. B. Wolf
(+ more)
2011
Journal of Immunology
doi:10.4049/jimmunol.1003682
pmcid:PMC3377446
pmid:21555531
|
web.archive.org
[PDF]
|
[b10]
via grobid
|
Activation of Tumor-specific CD4+T Lymphocytes by Major Histocompatibility Complex Class II Tumor Cell Vaccines
Samudra K. Dissanayake,
James A. Thompson,
Jacobus J. Bosch,
Virginia K. Clements,
Peter W. Chen,
Bruce R. Ksander,
Suzanne Ostrand-Rosenberg
2004
Cancer Research
doi:10.1158/0008-5472.can-03-2634
pmid:14996751
|
web.archive.org
[PDF]
|
[b11]
via grobid
|
The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes
James A. Thompson,
Minu K. Srivastava,
Jacobus J. Bosch,
Virginia K. Clements,
Bruce R. Ksander,
Suzanne Ostrand-Rosenberg
2007
Cancer Immunology and Immunotherapy
doi:10.1007/s00262-007-0381-5
pmcid:PMC2810506
pmid:17724589
|
web.archive.org
[PDF]
|
[b12]
via grobid
|
MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells
Minu K. Srivastava,
Jacobus J. Bosch,
Ashley L. Wilson,
Martin J. Edelman,
Suzanne Ostrand-Rosenberg
2010
International Journal of Cancer
doi:10.1002/ijc.25462
pmcid:PMC2947152
pmid:20473949
|
|
[b13]
via grobid
|
Armstrong TD, Clements VK, Ostrand-Rosenberg S. MHC class II-transfected tumor cells directly present antigen to tumor-specific CD4+ T lymphocytes. J Immunol. 1998; 160:661-66.
|
|
[b14]
via grobid
|
Ostrand-Rosenberg S, Thakur A, Clements V. Rejection of mouse sarcoma cells after transfection of MHC class II genes. J Immunol. 1990; 144:4068-71.
|
|
[b15]
via grobid
|
Pulaski BA, Ostrand-Rosenberg S. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res. 1998; 58:1486-93.
|
|
[b16]
via grobid
|
Immunotherapy with vaccines combining MHC class II/CD80 + tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon γ
Beth A. Pulaski,
Virginia K. Clements,
Matthew R. Pipeling,
Suzanne Ostrand-Rosenberg
2000
Cancer Immunology and Immunotherapy
doi:10.1007/s002620050024
pmcid:PMC11037012
pmid:10782864
|
|
[b17]
via grobid
|
Cutting Edge: CD4+ T Cell Help Can Be Essential for Primary CD8+ T Cell Responses In Vivo
J.-C. E. Wang,
A. M. Livingstone
2003
Journal of Immunology
doi:10.4049/jimmunol.171.12.6339
pmid:14662830
|
web.archive.org
[PDF]
|
[b18]
via grobid
|
Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
J-A Keene
1982
Journal of Experimental Medicine
doi:10.1084/jem.155.3.768
pmcid:PMC2186611
pmid:6801178
|
web.archive.org
[PDF]
|
[b19]
via grobid
|
Induction of a CD8+Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+T Cell Help
Sally R.M. Bennett,
Francis R. Carbone,
Freda Karamalis,
Jacques F.A.P. Miller,
William R. Heath
1997
Journal of Experimental Medicine
doi:10.1084/jem.186.1.65
pmcid:PMC2198964
pmid:9206998
|
web.archive.org
[PDF]
|
[b20]
via grobid
|
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Sally R. M. Bennett,
Francis R. Carbone,
Freda Karamalis,
Richard A. Flavell,
Jacques F. A. P. Miller,
William R. Heath
1998
Nature
doi:10.1038/30996
pmid:9624004
|
|
[b21]
via grobid
|
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Stephen P. Schoenberger,
Rene E. M. Toes,
Ellen I. H. van der Voort,
Rienk Offringa,
Cornelis J. M. Melief
1998
Nature
doi:10.1038/31002
pmid:9624005
|
|
[b22]
via grobid
|
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
John Paul Ridge,
Francesca Di Rosa,
Polly Matzinger
1998
Nature
doi:10.1038/30989
pmid:9624003
|
|
[b23]
via grobid
|
Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory
D. J. Shedlock
2003
Science
doi:10.1126/science.1082305
pmid:12690201
|
|
[b24]
via grobid
|
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Edith M. Janssen,
Edward E. Lemmens,
Tom Wolfe,
Urs Christen,
Matthias G. von Herrath,
Stephen P. Schoenberger
2003
Nature
doi:10.1038/nature01441
pmid:12594515
|
web.archive.org
[PDF]
|
[b25]
via grobid
|
CD4 + T Cell–Mediated Tumor Rejection Involves Inhibition of Angiogenesis that Is Dependent on IFNγ Receptor Expression by Nonhematopoietic Cells
Zhihai Qin,
Thomas Blankenstein
2000
Immunity
doi:10.1016/s1074-7613(00)80218-6
pmid:10894167
|
web.archive.org
[PDF]
|
[b26]
via grobid
|
CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function
Arata Takeuchi,
Takashi Saito
2017
Frontiers in Immunology
doi:10.3389/fimmu.2017.00194
pmcid:PMC5321676
pmid:28280496
|
web.archive.org
[PDF]
|
[b27]
via grobid
|
Thomas WD, Hersey P. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J Immunol. 1998; 161:2195-200.
|
|
[b28]
via grobid
|
Schattner EJ, Mascarenhas J, Bishop J, Yoo DH, Chadburn A, Crow MK, Friedman SM. CD4+ T-cell induction of Fas- mediated apoptosis in Burkitt's lymphoma B cells. Blood. 1996; 88:1375-82.
|
|
[b29]
via grobid
|
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+T reg cells
Weihong Liu,
Amy L. Putnam,
Zhou Xu-yu,
Gregory L. Szot,
Michael R. Lee,
Shirley Zhu,
Peter A. Gottlieb,
Philipp Kapranov
(+ more)
2006
Journal of Experimental Medicine
doi:10.1084/jem.20060772
pmcid:PMC2118339
pmid:16818678
|
web.archive.org
[PDF]
|